Glucoză Infomed Fluids

Glucoză Infomed Fluids is an intravenous solution containing glucose monohydrate as the active ingredient. The product is supplied as a sterile fluid for parenteral administration; the specific concentration is not disclosed in the available data. It is manufactured for the European market and is classified as an IV carbohydrate solution used in clinical settings for energy provision and fluid management during treatment and patient care.

Glucoză Infomed Fluids is employed in several clinical situations where rapid glucose delivery and fluid replacement are required.

- Management of hypoglycemia when oral glucose is not feasible. - Component of parenteral nutrition regimens for patients unable to receive enteral feeding. - Support of fluid and electrolyte balance during peri‑operative care. - Provision of an energy substrate during prolonged fasting or critical illness. - Adjunctive therapy for patients receiving intravenous medications that may lower blood glucose. - Use as a diluent for certain intravenous drug preparations requiring a carbohydrate carrier.

When administered intravenously, Glucoză Infomed Fluids may be associated with a range of observed effects, most of which are related to its glucose content and osmolarity.

Common: - Transient hyperglycemia, especially in patients with impaired insulin response. - Mild local irritation at the infusion site. - Electrolyte shifts such as mild hyponatremia. - Increased urine output due to osmotic diuresis. - Nausea or vomiting when infused rapidly. - Headache related to rapid changes in plasma glucose.

Serious: - Severe hyperglycemia leading to osmotic diuresis and dehydration. - Hypotension or fluid overload in patients with compromised cardiac function. - Allergic or anaphylactoid reaction to the solution constituents.

Clinical use of Glucoză Infomed Fluids requires careful assessment of patient condition and monitoring to minimize risks.

- Verify blood glucose level before and during infusion to avoid extreme hyperglycemia. - Assess cardiac and renal function, as excess fluid may precipitate overload. - Adjust infusion rate in patients with known electrolyte disturbances. - Use caution in pregnant or lactating individuals; safety data are limited. - Avoid administration to patients with known hypersensitivity to glucose solutions. - Monitor serum electrolytes and osmolality regularly during prolonged therapy. - Ensure aseptic technique to prevent catheter‑related infections.

Glucoză Infomed Fluids can influence the pharmacokinetics or pharmacodynamics of several concurrently administered agents.

Avoid: - Concurrent high‑dose insulin therapy without glucose monitoring, which may precipitate severe hypoglycemia. - Co‑administration with other hypertonic carbohydrate solutions, increasing risk of fluid overload. - Use with medications that contain potassium or other electrolytes in concentrations that could exacerbate electrolyte imbalance.

Use with caution: - Diuretics, which may amplify electrolyte shifts when combined with glucose infusion. - Beta‑adrenergic agonists, as they can enhance glycogenolysis and raise glucose levels. - Corticosteroids, which may increase blood glucose and require closer monitoring.